Pioneering microfluidics technologies to treat pregnant populations
26th April 2023
A research group at the University of Manitoba is using microfluidics technologies from Dolomite Microfluidics to design and evaluate novel nanoparticle drug delivery systems for the safe and effective treatment of diseases during pregnancy. The laboratory has developed an innovative microfluidics model to mimic the structure of the placenta, and is using this system to assess the potential of new nanoparticle-based therapies for serious congenital diseases, such as diaphragmatic hernia.
Blacktrace launches Particle Works – the new dedicated particle engineering brand
7th April 2022
Blacktrace Holdings Ltd is excited to announce the launch of Particle Works, a spin out of Dolomite Microfluidics.
Microfluidics offers easier and faster manufacturing of nanomedicines
30th June 2021
Researchers at Queen's University Belfast are using microfluidics to fabricate particles for the encapsulation of drugs and biologics for imaging, treatment and cell targeting.
Dolomite Microfluidics and Phosphorex partner to accelerate lipid nanoparticle development in the fields of drug delivery and nanomedicine
1st June 2021
Dolomite Microfluidics and Phosphorex, Inc. are pleased to announce their partnership to establish unique capabilities in drug and vaccine development.
Dolomite Microfluidics launches Automated Nanoparticle System for formulation library generation
23rd March 2021